GSK’s Bepirovirsen Delivers Landmark Phase 3 Cure Data
LONDON, UK, May 28, 2026 GSK has announced groundbreaking Phase III clinical trial results for bepirovirsen, its investigational antisense...
Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
LONDON, UK, May 28, 2026 GSK has announced groundbreaking Phase III clinical trial results for bepirovirsen, its investigational antisense...
SEATTLE and SINGAPORE, May 27, 2026 Callio Therapeutics has announced the presentation of its Phase 1 clinical trial design...
BASEL, Switzerland, May 27, 2026 Roche has announced the launch of its groundbreaking Liver Disease Panel, the healthcare industry’s...
